CUFinder

Gaurav Singal

Gaurav Singal

Harvard University

H-index: 17

North America-United States

Contact Gaurav Singal

About Gaurav Singal

Gaurav Singal, With an exceptional h-index of 17 and a recent h-index of 15 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Medicine, Data Science, Biomarkers, Novel Trial Design, Health Technology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors

Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic …

Real-world (RW) outcomes for advanced non-small cell lung cancer (aNSCLC) patients (pts) with EGFR exon 19 deletions (x19del) stratified by deletion size.

Characteristics and outcomes of real-world (RW) patients (pts) with microsatellite instability-high (MSI-H) solid tumors treated with pembrolizumab monotherapy (P) after FDA …

Association of BRCA alteration (alt) type with real-world (RW) outcomes to PARP inhibitors (PARPi) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database (vol 321, pg …

Gaurav Singal Information

University

Position

Brigham and Women’s Hospital

Citations(all)

2606

Citations(since 2020)

2355

Cited By

1075

hIndex(all)

17

hIndex(since 2020)

15

i10Index(all)

22

i10Index(since 2020)

19

Email

University Profile Page

Google Scholar

Gaurav Singal Skills & Research Interests

Medicine

Data Science

Biomarkers

Novel Trial Design

Health Technology

Top articles of Gaurav Singal

Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response

Cancer Discovery

2021/2/1

Karthikeyan Murugesan
Karthikeyan Murugesan

H-Index: 7

Radwa Sharaf
Radwa Sharaf

H-Index: 10

Virginia Fisher
Virginia Fisher

H-Index: 12

Gaurav Singal
Gaurav Singal

H-Index: 11

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Journal for immunotherapy of cancer

2021

Hao Xu
Hao Xu

H-Index: 3

Michael E Goldberg
Michael E Goldberg

H-Index: 12

Karthikeyan Murugesan
Karthikeyan Murugesan

H-Index: 7

Jianhua Zhang
Jianhua Zhang

H-Index: 22

Jack Lee
Jack Lee

H-Index: 22

Gaurav Singal
Gaurav Singal

H-Index: 11

Jianjun Zhang
Jianjun Zhang

H-Index: 12

Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors

JAMA Network Open

2020/10/1

Gaurav Singal
Gaurav Singal

H-Index: 11

Fan Jin
Fan Jin

H-Index: 32

Wei Zhou
Wei Zhou

H-Index: 2

Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic …

Lung Cancer

2020/10/1

Jeremy Snider
Jeremy Snider

H-Index: 11

Gaurav Singal
Gaurav Singal

H-Index: 11

Real-world (RW) outcomes for advanced non-small cell lung cancer (aNSCLC) patients (pts) with EGFR exon 19 deletions (x19del) stratified by deletion size.

2020/5/20

Sai-Hong Ignatius Ou
Sai-Hong Ignatius Ou

H-Index: 69

Jeremy Snider
Jeremy Snider

H-Index: 11

Gaurav Singal
Gaurav Singal

H-Index: 11

Characteristics and outcomes of real-world (RW) patients (pts) with microsatellite instability-high (MSI-H) solid tumors treated with pembrolizumab monotherapy (P) after FDA …

2020/5/20

Jeremy Snider
Jeremy Snider

H-Index: 11

Gaurav Singal
Gaurav Singal

H-Index: 11

Association of BRCA alteration (alt) type with real-world (RW) outcomes to PARP inhibitors (PARPi) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).

2020/5/20

Jeremy Snider
Jeremy Snider

H-Index: 11

Gaurav Singal
Gaurav Singal

H-Index: 11

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database (vol 321, pg …

Jama

2019/4/9

Gaurav Singal
Gaurav Singal

H-Index: 11

Peter G Miller
Peter G Miller

H-Index: 31

Ivan Ivanov
Ivan Ivanov

H-Index: 4

Jie He
Jie He

H-Index: 12

Mark Bailey
Mark Bailey

H-Index: 4

B08 Impact of Concurrent STK11 Loss and c-MYC Amplification in Metastatic Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

2020/2/1

See List of Professors in Gaurav Singal University(Harvard University)